Viewing Study NCT02027961


Ignite Creation Date: 2025-12-24 @ 12:43 PM
Ignite Modification Date: 2026-02-02 @ 5:22 AM
Study NCT ID: NCT02027961
Status: COMPLETED
Last Update Posted: 2019-05-17
First Post: 2013-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
Sponsor: MedImmune LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module